NCT06967220

Brief Summary

The main goal is to elucidate the mechanistic coupling between inflammation and the ability to maintain skeletal muscle through physical exercise while hospitalized. We will investigate protein kinetics in patients who belong to one of three groups 1) high inflammatory state, 2) moderate inflammatory state and 3) low/no inflammation. We will further intervene in group 1 (high inflammatory state) with anti-inflammatory nutrition (primarily green-solution plant-based) to diminish activity in inflammatory pathways. The hypothesis is that inflammation will inhibit protein synthesis in skeletal muscle both in resting muscle and in strength trained skeletal musculature, and that a lowering of the inflammatory status by anti-inflammatory nutrition will enhance the exercise induced formation of new muscle mass. .

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2025

Completed
25 days until next milestone

Study Start

First participant enrolled

May 12, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2026

Completed
Last Updated

May 15, 2025

Status Verified

April 1, 2025

Enrollment Period

12 months

First QC Date

April 17, 2025

Last Update Submit

May 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • FSR in high vs. low inflammation group

    The primary outcome is the muscle protein fractional synthesis rate (FSR) in the high inflammation group vs. the low inflammation group

    7 days (or until hospital discharge)

Secondary Outcomes (7)

  • Change in muscle size between groups

    7 days (or until hospital discharge)

  • FSR in trained vs. non trained leg

    7 days (or until hospital discharge)

  • Inflammation in regular vs. antiinflammatory diet

    7 days (or until hospital discharge)

  • AA uptake following feeding

    7 days (or until hospital discharge)

  • Muscle size in trained vs. untrained leg

    7 days (or until hospital discharge)

  • +2 more secondary outcomes

Other Outcomes (1)

  • Feasibility of training

    7 days (or until hospital discharge)

Study Arms (1)

Anti-inflammatory diet and supplements

EXPERIMENTAL

A sub group of patients with high inflammation will be offered a diet where 50% of the regular hospital diet is switched for diet containing plant based food and nutrients found to lower inflammation

Other: Single leg training

Interventions

All subjects will train one leg twice daily.

Anti-inflammatory diet and supplements

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Hospitalised at the geriatric department at Bispebjerg Hospital with an expected admission time of minimum 7 days
  • Have Disease Related Malnutrition (DRM)
  • Able to carry out strength training
  • Able to understand the study information, as assessed by the research team

You may not qualify if:

  • Current use of anti-inflammatory medication
  • Liver failure
  • Short bowel syndrome
  • Chrohn's or colitis
  • Terminally ill

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bispebjerg Hospital

Copenhagen, 2400, Denmark

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

April 17, 2025

First Posted

May 13, 2025

Study Start

May 12, 2025

Primary Completion

April 22, 2026

Study Completion

April 22, 2026

Last Updated

May 15, 2025

Record last verified: 2025-04

Locations